These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32845232)

  • 1. Validation of Microsimulation Models against Alternative Model Predictions and Long-Term Colorectal Cancer Incidence and Mortality Outcomes of Randomized Controlled Trials.
    Lew JB; Greuter MJE; Caruana M; He E; Worthington J; St John DJ; Macrae FA; Feletto E; Coupé VMH; Canfell K
    Med Decis Making; 2020 Aug; 40(6):815-829. PubMed ID: 32845232
    [No Abstract]   [Full Text] [Related]  

  • 2. Modeling in Colorectal Cancer Screening: Assessing External and Predictive Validity of MISCAN-Colon Microsimulation Model Using NORCCAP Trial Results.
    Buskermolen M; Gini A; Naber SK; Toes-Zoutendijk E; de Koning HJ; Lansdorp-Vogelaar I
    Med Decis Making; 2018 Nov; 38(8):917-929. PubMed ID: 30343626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced incidence and mortality from colorectal cancer with flexible-sigmoidoscopy screening: a meta-analysis.
    Shroff J; Thosani N; Batra S; Singh H; Guha S
    World J Gastroenterol; 2014 Dec; 20(48):18466-76. PubMed ID: 25561818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Number of Adenomas Removed and Colorectal Cancers Prevented in Randomized Trials of Flexible Sigmoidoscopy Screening.
    Pinsky PF; Loberg M; Senore C; Wooldrage K; Atkin W; Bretthauer M; Cross AJ; Hoff G; Holme O; Kalager M; Segnan N; Schoen RE
    Gastroenterology; 2018 Oct; 155(4):1059-1068.e2. PubMed ID: 29935150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of Colorectal Cancer Models on Long-term Outcomes from a Randomized Controlled Trial.
    DeYoreo M; Lansdorp-Vogelaar I; Knudsen AB; Kuntz KM; Zauber AG; Rutter CM
    Med Decis Making; 2020 Nov; 40(8):1034-1040. PubMed ID: 33078673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Screening Modalities in Colorectal Cancer: A Network Meta-Analysis.
    Zhang J; Cheng Z; Ma Y; He C; Lu Y; Zhao Y; Chang X; Zhang Y; Bai Y; Cheng N
    Clin Colorectal Cancer; 2017 Dec; 16(4):252-263. PubMed ID: 28687458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Effectiveness of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality in Women and Men: A Randomized Trial.
    Holme Ø; Løberg M; Kalager M; Bretthauer M; Hernán MA; Aas E; Eide TJ; Skovlund E; Lekven J; Schneede J; Tveit KM; Vatn M; Ursin G; Hoff G;
    Ann Intern Med; 2018 Jun; 168(11):775-782. PubMed ID: 29710125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of overdiagnosis in colorectal cancer screening with sigmoidoscopy and faecal occult blood testing: comparison of simulation models.
    Wieszczy P; Kaminski MF; Løberg M; Bugajski M; Bretthauer M; Kalager M
    BMJ Open; 2021 Apr; 11(4):e042158. PubMed ID: 33853794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials.
    Elmunzer BJ; Hayward RA; Schoenfeld PS; Saini SD; Deshpande A; Waljee AK
    PLoS Med; 2012; 9(12):e1001352. PubMed ID: 23226108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Lin JS; Piper MA; Perdue LA; Rutter CM; Webber EM; O'Connor E; Smith N; Whitlock EP
    JAMA; 2016 Jun; 315(23):2576-94. PubMed ID: 27305422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trial.
    Miller EA; Pinsky PF; Schoen RE; Prorok PC; Church TR
    Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):101-110. PubMed ID: 30502933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calibration and Validation of the Colorectal Cancer and Adenoma Incidence and Mortality (CRC-AIM) Microsimulation Model Using Deep Neural Networks.
    Vahdat V; Alagoz O; Chen JV; Saoud L; Borah BJ; Limburg PJ
    Med Decis Making; 2023 Aug; 43(6):719-736. PubMed ID: 37434445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing colorectal cancer or early diagnosis: Which is best? A re-analysis of the U.S. Preventive Services Task Force Evidence Report.
    Swartz AW; Eberth JM; Strayer SM
    Prev Med; 2019 Jan; 118():104-112. PubMed ID: 30367971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE.
    Segnan N; Armaroli P; Bonelli L; Risio M; Sciallero S; Zappa M; Andreoni B; Arrigoni A; Bisanti L; Casella C; Crosta C; Falcini F; Ferrero F; Giacomin A; Giuliani O; Santarelli A; Visioli CB; Zanetti R; Atkin WS; Senore C;
    J Natl Cancer Inst; 2011 Sep; 103(17):1310-22. PubMed ID: 21852264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline.
    Peterse EFP; Meester RGS; Siegel RL; Chen JC; Dwyer A; Ahnen DJ; Smith RA; Zauber AG; Lansdorp-Vogelaar I
    Cancer; 2018 Jul; 124(14):2964-2973. PubMed ID: 29846933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality From Postscreening (Interval) Colorectal Cancers Is Comparable to That From Cancer in Unscreened Patients-A Randomized Sigmoidoscopy Trial.
    Jodal HC; Løberg M; Holme Ø; Adami HO; Bretthauer M; Emilsson L; Ransohoff DF; Hoff G; Kalager M
    Gastroenterology; 2018 Dec; 155(6):1787-1794.e3. PubMed ID: 30165051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of screening for colorectal cancer: Development, documentation and validation of a multistate Markov model.
    Heisser T; Hoffmeister M; Brenner H
    Int J Cancer; 2021 Apr; 148(8):1973-1981. PubMed ID: 33320964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evidence-based microsimulation model for colorectal cancer: validation and application.
    Rutter CM; Savarino JE
    Cancer Epidemiol Biomarkers Prev; 2010 Aug; 19(8):1992-2002. PubMed ID: 20647403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection versus primary prevention in the PLCO flexible sigmoidoscopy screening trial: Which has the greatest impact on mortality?
    Doroudi M; Schoen RE; Pinsky PF
    Cancer; 2017 Dec; 123(24):4815-4822. PubMed ID: 28976536
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.